LUIS JOSE FERNANDEZ LEDESMA, Head of TME Labs, CTO Microliquid, Co-Founder BEONCHIP

Dr Luis J. Fernandez is the Head of Tissue Microenvironment Lab (TME Lab), a research group from the University of Zaragoza (Spain) focused on the Understanding, Mimicking and Preservation of cell and tissue Microenvironment to find new therapeutic strategies and new personalized treatments to patients.
Dr Luis J Fernandez has 20 years of experience on microengineering, including cell culture microfluidic systems for organ-on-chip applications, microfluidics-based in-vitro diagnosis systems, microfluidic manufacturing, drug delivery and tissue monitoring microdevices, and BioMEMS. His research interest focuses on the generation of new scientific approaches to impact Biomedical Research, Industry and Clinical Practice. He has published more than 50 scientific papers with SCI and 21 patents and know-how transfers (11 of which are currently under exploitation).
During the last 10 years, he worked as PI for the involvement of his group on 7 H2020 competitive European projects and 12 National competitive projects.
Dr. Luis J Fernandez is Member of the Internal Scientific Committee of Aragon Health Research Institute (IISA), Member of the Research Committee and Postgrad at the “Aragon Institute of Engineering Research” (I3A), and He was awarded the National Grant “Torres Quevedo” (for senior researchers joining private companies) in 2006 and with the Internationally open Grant “Ramon y Cajal Fellowship” (for experienced researchers to be incorporated as a permanent staff within public Universities of Spain) in 2010.
He is co-founder of Beonchip SL, a company dedicated to the development and commercialization of microfluidic devices for organ-on-chip applications, partner of EBERS Medical Technology, a company dedicated to the development and commercialization of equipment for tissue engineering and organ transplantation, and partner Director and CTO of Microliquid, a company dedicated to the development and mass manufacturing of In-vitro diagnostic and drug delivery microfluidics devices for third companies.